Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial
UK Clinical studies have indicated that Tesamorelin may reduce body fat and visceral adipose tissue and improve insulin sensitivity, suggesting its potential for supporting those with metabolic challenges like diabetes mellitus
VK0214, oral TR agonist for X-linked adrenoleukodystrophy (X-ALD) Recent Highlights: In June 2026, Viking announced that its working toward maintenance-dosing data for subcutaneous VK2735 and preparing to start Phase 3 trials of the oral tablet in Q4 2026, with the goal of becoming the first company to offer a dual GLP-1/GIP agonist in both oral and injectable form
In addition to its essential roles in redox homeostasis it functions as cofactors for a multitude of enzymes
US$ 25.71
US$ 22.55
US$ 24.74
US$ 20.08
US$ 29.17
US$ 28.42
US$ 20.62
US$ 26.42
US$ 21.87
US$ 21.49
US$ 28.79
US$ 21.64
US$ 27.71
